AstraZeneca at PEGS Europe 2026
Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website
AstraZeneca brings 15 presentations to PEGS Europe 2026 in Lisbon. Its program centres on machine learning and automation across biologics work, from lead optimisation and stability prediction for multispecific antibodies to peptide design. It also covers T cell engagers tuned toward CD8 effector cells and masks for protease-activated biologics.
| Organization | PEGS Europe 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global pharmaceutical company with oncology, immunology, respiratory and rare disease medicines, including antibodies and ADCs. | Talk Tue Nov 17 9:30am–10:00am Chair Tue Nov 17 11:44am–11:45am Chair Tue Nov 17 2:00pm–2:05pm Talk Tue Nov 17 5:20pm–5:50pm Panel Tue Nov 17 5:50pm–6:20pm Talk Tue Nov 17 5:50pm–6:20pm Chair Wed Nov 18 8:25am–8:30am Talk Wed Nov 18 11:15am–11:45am Talk Wed Nov 18 11:45am–12:15pm Chair Thu Nov 19 8:25am–8:30am Talk Thu Nov 19 8:30am–8:50am Talk Thu Nov 19 9:00am–9:30am Talk Thu Nov 19 11:15am–11:45am Talk Thu Nov 19 11:45am–12:05pm Talk Thu Nov 19 5:15pm–5:45pm |
Instantly find 20 buyers from AstraZeneca
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction